Claudia Balotta
Overview
Explore the profile of Claudia Balotta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1084
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lo Presti A, Andriamandimby S, Lai A, Angeletti S, Cella E, Mottini G, et al.
Pathog Glob Health
. 2017 Jan;
111(1):23-30.
PMID: 28081689
Africa is one of the endemic regions of HBV infection. In particular, genotype E is highly endemic in most of sub-Saharan Africa such as West African countries where it represents...
12.
Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, et al.
Infect Genet Evol
. 2016 Jun;
46:169-179.
PMID: 27262355
Human immunodeficiency virus type 1 (HIV-1) was discovered in the early 1980s when the virus had already established a pandemic. For at least three decades the epidemic in the Western...
13.
Lai A, Bozzi G, Franzetti M, Binda F, Simonetti F, De Luca A, et al.
PLoS One
. 2016 Jan;
11(1):e0146097.
PMID: 26752062
Background: Subtype A accounts for only 12% of HIV-1 infections worldwide but predominates in Russia and Former Soviet Union countries of Eastern Europe. After an early propagation via heterosexual contacts,...
14.
Angelis K, Albert J, Mamais I, Magiorkinis G, Hatzakis A, Hamouda O, et al.
J Infect Dis
. 2014 Dec;
211(11):1735-44.
PMID: 25512631
Background: Human immunodeficiency virus type 1 (HIV-1) subtype CRF01_AE originated in Africa and then passed to Thailand, where it established a major epidemic. Despite the global presence of CRF01_AE, little...
15.
Frentz D, van de Vijver D, Abecasis A, Albert J, Hamouda O, Jorgensen L, et al.
BMC Infect Dis
. 2014 Jul;
14:407.
PMID: 25047543
Background: One out of ten newly diagnosed patients in Europe was infected with a virus carrying a drug resistant mutation. We analysed the patterns over time for transmitted drug resistance...
16.
Franzetti M, Violin M, Antinori A, De Luca A, Ceccherini-Silberstein F, Gianotti N, et al.
BMC Infect Dis
. 2014 Jul;
14:398.
PMID: 25037229
Background: Despite a substantial reduction in virological failures following introduction of new potent antiretroviral therapies in the latest years, drug resistance remains a limitation for the control of HIV-1 infection....
17.
Pineda-Pena A, Schrooten Y, Vinken L, Ferreira F, Li G, Trovao N, et al.
PLoS One
. 2014 Jul;
9(7):e101738.
PMID: 25003369
We aimed to study epidemic trends and predictors for transmitted drug resistance (TDR) in our region, its clinical impact and its association with transmission clusters. We included 778 patients from...
18.
Frentz D, Vijver D, Abecasis A, Albert J, Hamouda O, Jorgensen L, et al.
PLoS One
. 2014 Apr;
9(4):e94495.
PMID: 24721998
Background: In Europe, a continuous programme (SPREAD) has been in place for ten years to study transmission of drug resistant HIV. We analysed time trends of transmitted drug resistance mutations...
19.
Simonetti F, Lai A, Monno L, Binda F, Brindicci G, Punzi G, et al.
Infect Genet Evol
. 2014 Mar;
23:176-81.
PMID: 24602697
HIV-1 recombination, reverse transcriptase (RT) low fidelity and high replication rate are the drivers of variability and evolution on the global scale. Only few of these HIV-1 chimeric forms have...
20.
Lai A, Bozzi G, Franzetti M, Binda F, Simonetti F, Micheli V, et al.
J Med Virol
. 2014 Feb;
86(5):729-36.
PMID: 24482324
The HIV-1 clade C is prevalent worldwide and spread from Africa to South East Asia and South America early in the course of the epidemic. As a consequence of migration...